[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals (REGN) Faces Securities Class Action After Losing $9 Billion Value Following Q3 2024 Earnings Report- Hagens Berman",
    "summary": "SAN FRANCISCO, Jan. 9, 2025 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. faces a securities fraud class action after shares of the company plunged $84.59 on Oct. 31, 2024, wiping out about $9...",
    "url": "https://finnhub.io/api/news?id=684385d6f7f78248f092accadd40c2c21b0c6767e0abdea1bb11ebd90b0fa2f0",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736432765,
      "headline": "Regeneron Pharmaceuticals (REGN) Faces Securities Class Action After Losing $9 Billion Value Following Q3 2024 Earnings Report- Hagens Berman",
      "id": 132351202,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "SAN FRANCISCO, Jan. 9, 2025 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. faces a securities fraud class action after shares of the company plunged $84.59 on Oct. 31, 2024, wiping out about $9...",
      "url": "https://finnhub.io/api/news?id=684385d6f7f78248f092accadd40c2c21b0c6767e0abdea1bb11ebd90b0fa2f0"
    }
  }
]